Clean Your Email List with Our Free Verifier Tool! ➡️ Verify Emails Now🚀
ASTHMA IS COMPLICATED. WE BELIEVE WE CAN MAKE IT SIMPLER. Airway inflammation is the major underlying cause of asthma. FeNO is a biomarker of Type 2 inflammation and FeNO testing can help achieve better management and outcomes in asthma patients. Circassia is the world leader in FeNO testing. Our NIOX products are used by specialists throughout the UK and around the world. NIOX VERO, THE GOLD STANDARD IN FENO TESTING With over 40 million FeNO tests performed worldwide, NIOX VERO helps healthcare professionals to accurately measure Type 2 airway inflammation. NIOX technology eliminates the impact of environmental nitric oxide and ensures you get an accurate FeNO result each time, every time. NIOX VERO can help with: - Diagnosis: Identifying Type 2 inflammation and assisting in asthma diagnosis - Treatment: Identifying patients likely to respond to ICS and optimising ICS dosage - Compliance: Uncovering non-adherence to ICS treatment - Quality of life: Predicting exacerbations and reducing exacerbation rate by up to 50% - Severe asthma: Identifying appropriate patients for some biologics and monitoring response to biologics Find out more about NIOX VERO here: https://niox.com View More
